Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina Inc (NQ: ILMN )

110.13 -1.22 (-1.10%)
Streaming Delayed Price Updated: 11:24 AM EDT, May 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Illumina Inc

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Time100 Most Influential Companies: What 61 Publicly Traded Companies Are On The Inaugural List?
Time Magazine is well-known for its annual Time100 Most Influential People issue. The media brand unveiled a new annual list called the TIME100 Most Influential Companies. ... 
Via Benzinga
How Illumina's Q1 Results Delighted Investors
Nearly everything went right for the genomic sequencing pioneer. 
Via The Motley Fool
Earnings Scheduled For April 27, 2021
Companies Reporting Before The Bell • Camden National (NASDAQ:CAC) is projected to report quarterly earnings at $1.01 per share on revenue of $45.73 million. •... 
Via Benzinga
Illumina stock rises on stronger sales, bullish outlook
Wells Fargo and Canaccord raised their price targets on Illumina's stock following the preliminary results. 
Via Talk Markets
Illumina Inc (ILMN) Q1 2021 Earnings Call Transcript
ILMN earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Illumina: Q1 Earnings Insights
Shares of Illumina (NASDAQ:ILMN) rise in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 15.24% year over year to $1.89,... 
Via Benzinga
Illumina Stock Dips Despite First-Quarter Beat, Strong Earnings Guide
Illumina stock skidded on Tuesday after the medical technology giant reported adjusted income of $1.89 per share on $1.09 billion in sales. 
Via Investor's Business Daily
Tuesday Market Report
Swiss ABB gained 0.8% more today after it reported on its Q1 today, confirming the pre-announced data from earlier in April. 
Via Talk Markets
3 Healthcare Stocks About to be Bolstered by Biden's American Rescue Plan
The government is going to invest heavily in COVID-19 research and tracking, and these companies are likely to benefit. 
Via The Motley Fool
Exposures COVID-19
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Illumina, Kartos Therapeutics Team Up To Develop Companion Diagnostic For TP53-Haboring Cancer Indications
Illumina Inc (NASDAQ: ILMN) and privately-held Kartos Therapeutics have announced a partnership to develop a next-generation sequencing-based TP53 companion... 
Via Benzinga
Tesla Hit As The QQQ, SPY And DIA All Fell Today. Here's Why.
U.S. indices traded lower Thursday on reports President Biden will propose a capital gains tax for the wealthy of up to 43.4%, which... 
Via Benzinga
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:... 
Via Benzinga
Exposures Product Safety
The QQQ, SPY And DIA All Fell Today. Here's Why.
U.S. indices traded lower Monday amid weakness in tech stocks and potential profit-taking in financials. The Invesco QQ... 
Via Benzinga
The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:... 
Via Benzinga
3 Biden Healthcare Stocks to Watch
The administration's focus on the Affordable Care Act, access to healthcare, and research may accelerate growth for these three stocks. 
Via The Motley Fool
Is Illumina Still a Buy Without the GRAIL Acquisition?
Sometimes the most carefully laid plans hit unforeseen snags. 
Via The Motley Fool
Topics Lawsuit
Exposures Financial Legal
The Big Questions for Illumina After Its Q1 Sneak Peek and 2021 Guidance
The gene sequencing giant has a couple of key challenges going forward. 
Via The Motley Fool
Ginkgo Bioworks, Which Prints DNA And Creates Genetically Modified Food, Exploring SPAC Deal: Report
One of the largest SPACs seeking a target could be nearing a $20 billion deal to bring one of the largest privately-held biotechnology companies public. The SPAC Rumor: Bloomberg... 
Via Benzinga
Biotech Stocks Hit A Snag — Why Experts Say The Heyday Isn't Over
Regulatory and drug-pricing worries have knocked biotech stocks off their pedestal. After hitting a high point in February, biotech stocks have fallen 20%. 
Via Investor's Business Daily
Exposures COVID-19
Stock Market Rally Gains Steam As Apple, Microsoft, Google, Facebook Lead Tech Revival: Weekly Review
The Nasdaq fully joined the market rally, as Microsoft, Google and Facebook broke out while Apple and other growth stocks rebounded. The S&P 500 hit ahigh. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
This Unstoppable Stock Doesn't Pay a Dividend Yet, but It Could
This giant of the genomic revolution ticks nearly all the boxes dividend investors should look for. 
Via The Motley Fool
Could Illumina's Quest to Acquire GRAIL Fail?
The chances are certainly higher now that the deal won't happen. 
Via The Motley Fool
Why Illumina Stock Fell 12.6% in March
The biotech was under pressure last month, but it's bouncing back in April. 
Via The Motley Fool
51 Biggest Movers From Yesterday
Gainers UTime Limited (NASDAQ: UTME) shares jumped 875% to close at $39.00 on Tuesday after the company priced its IPO at $4 per share. Romeo Power, Inc. (NYSE: RMO) climbed 59.6... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Why Illumina Stock Just Jumped 10%
The DNA sequencing company is gearing up to report a big beat later this month. 
Via The Motley Fool
P/E Ratio Insights for Illumina
In the current session, Illumina Inc. (NASDAQ:ILMN) is trading at $419.95, after a 9.21% spike. Over the past month, the stock increased by 4.76%, and in the past... 
Via Benzinga
33 Stocks Moving In Tuesday's Mid-Day Session
Gainers Scienjoy Holding Corporation (NASDAQ: SJ) shares jumped 67.4% to $16.04 after the company announced a strategic alliance with Snipp to launch a new loyalty and rewards... 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.